MedTrace Logo

HF Assessment With BNP in the Home: Part II

NCT02351063 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1

Last updated 2024-01-03

Study results available
· View outcomes & findings →

Summary

HABIT-II is a feasibility study aimed at home monitoring of patients with heart failure. B-type natriuretic peptide (BNP) has strong correlations to the severity of heart failure. Lower BNP levels are closely associated with better clinical outcomes. The goal of HABIT-II is to demonstrate that the results of daily patient self-testing of BNP at home will provide sufficient information to guide physicians to modify therapy and lower BNP levels over time.

Conditions

Interventions

DRUG

Changes of heart failure medications

Changes in dosage of existing medications or introduction of new medications to improve heart failure condition.

Sponsors & Collaborators

  • Alere San Diego

    lead INDUSTRY

Principal Investigators

  • Alan Maisel, MD · San Diego Veterans Administration Medical Center

  • Ken McDonald, MD · St Vincent's University Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-04-30
Primary Completion
2014-07-31
Completion
2014-07-31

Countries

  • United States
  • Ireland
  • Netherlands
  • New Zealand
  • Sweden
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02351063 on ClinicalTrials.gov